1. Home
  2. MIRA vs LSBPW Comparison

MIRA vs LSBPW Comparison

Compare MIRA & LSBPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIRA
  • LSBPW
  • Stock Information
  • Founded
  • MIRA 2020
  • LSBPW N/A
  • Country
  • MIRA United States
  • LSBPW China
  • Employees
  • MIRA N/A
  • LSBPW N/A
  • Industry
  • MIRA Biotechnology: Pharmaceutical Preparations
  • LSBPW Biotechnology: Pharmaceutical Preparations
  • Sector
  • MIRA Health Care
  • LSBPW Health Care
  • Exchange
  • MIRA Nasdaq
  • LSBPW Nasdaq
  • Market Cap
  • MIRA 10.9M
  • LSBPW 7.4M
  • IPO Year
  • MIRA 2023
  • LSBPW N/A
  • Fundamental
  • Price
  • MIRA $0.69
  • LSBPW $0.08
  • Analyst Decision
  • MIRA
  • LSBPW
  • Analyst Count
  • MIRA 0
  • LSBPW 0
  • Target Price
  • MIRA N/A
  • LSBPW N/A
  • AVG Volume (30 Days)
  • MIRA 1.7M
  • LSBPW N/A
  • Earning Date
  • MIRA 09-13-2024
  • LSBPW N/A
  • Dividend Yield
  • MIRA N/A
  • LSBPW N/A
  • EPS Growth
  • MIRA N/A
  • LSBPW N/A
  • EPS
  • MIRA N/A
  • LSBPW N/A
  • Revenue
  • MIRA N/A
  • LSBPW N/A
  • Revenue This Year
  • MIRA N/A
  • LSBPW N/A
  • Revenue Next Year
  • MIRA N/A
  • LSBPW N/A
  • P/E Ratio
  • MIRA N/A
  • LSBPW N/A
  • Revenue Growth
  • MIRA N/A
  • LSBPW N/A
  • 52 Week Low
  • MIRA $0.51
  • LSBPW N/A
  • 52 Week High
  • MIRA $6.95
  • LSBPW N/A
  • Technical
  • Relative Strength Index (RSI)
  • MIRA 49.12
  • LSBPW N/A
  • Support Level
  • MIRA $0.51
  • LSBPW N/A
  • Resistance Level
  • MIRA $0.89
  • LSBPW N/A
  • Average True Range (ATR)
  • MIRA 0.10
  • LSBPW 0.00
  • MACD
  • MIRA 0.02
  • LSBPW 0.00
  • Stochastic Oscillator
  • MIRA 38.21
  • LSBPW 0.00

About MIRA MIRA Pharmaceuticals Inc.

Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.

Share on Social Networks: